Showing results (821-830 of 876) with videos related to
Sort By:
Pageof 88
Translational Vision Science & Technology|March 14, 2023
AxoNet 2.0: A Deep Learning-Based Tool for Morphometric Analysis of Retinal Ganglion Cell AxonsVidisha Goyal, A Thomas Read, Matthew D Ritch, et al.Internal Medicine Journal|July 8, 2024
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern eraDiva Baggio, Eliza Chung, Cameron Wellard, et al.Cities & Health|December 5, 2024
Public acceptability of proposals to manage new takeaway food outlets near schools: cross-sectional analysis of the 2021 International Food Policy StudyMatthew Keeble, Jean Adams, Ben Amies-Cull, et al.Nature Communications|March 15, 2016
Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endotheliumBethany A Kerr, Xiaoxia Z West, Young-Woong Kim, et al.Blood Advances|September 9, 2025
Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN studyRamón García-Sanz, Roger G Owen, Wojciech Jurczak, et al.International Journal of Health Policy and Management|December 2, 2024
Retailer Responses to Public Consultations on the Adoption of Takeaway Management Zones Around Schools: A Longitudinal Qualitative AnalysisMatthew Keeble, Michael Chang, Daniel Derbyshire, et al.SSM - Population Health|April 23, 2024
Changes in the number of new takeaway food outlets associated with adoption of management zones around schools: A natural experimental evaluation in EnglandJohn Rahilly, Ben Amies-Cull, Michael Chang, et al.Molecular Psychiatry|May 1, 1997
Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB)K Blum, E R Braverman, S Wu, et al.Nature Medicine|November 17, 2023
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell diseaseMichael Spencer Chapman, Alyssa H Cull, Marioara F Ciuculescu, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2020
Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III studyM van der Meulen, K Bakunina, M Nijland, et al.Pageof 88